These lab-created options weren't made with recreational use in mind. Inside the nineties, John W. Huffman and a group of fellow chemists at Clemson University developed a number of the to start with formulation for synthetic cannabinoid receptor agonists (SCRAs), a household of substances that imitate the physiological and psychological impacts of